chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized on 7/22/22 to 7/25 due to COPD exacerbation secondary to COVID-19 infection. Admitted again on 7/30/22 and currently admitted on Observation Status with cough without much sputum, worsening headache and fever in the setting of COVID-19 infection.
EVALUATED IN EMERGENCY ROOM BY DR. WHO ASSESSED PATIENT AND RECOMMENED LORATADINE 10MG DAILY AND GILTUSS EVERY 6 HR FOR COUGH (Evaluated  in emergency room by Dr. who assessed  patient and recommended loratadine 10mg daily and giltuss every 6 HR for cough)
About 10 minutes after receiving vaccine patient became dizzy. BP 112/54, HR range 40-154, irregular on oscitation. Repeat BP 120/45, HR 105. 02 sat 100%. Patient was sent to the ER for further evaluation and monitoring.
This spontaneous report received from a medical assistant referred to 5 patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients was vaccinated with an improperly stored PROQUAD (lot: M041084: expiry date: 04-APR-2018) (incorrect product storage). The vaccine was stored at 15F for 4 hours and 30 minutes. Time frame was 45 minutes The call was due to a data logger. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1706USA001419:
Left Deltoid: Induration, warmth and tenderness. TReated with cephalexin on 7/31/20 Sx completely resolved on 8/07/2020.
An attorney alleges that a 4 year old male received an injection of Acel-Immune on 10/25/99. Sometime in 1998, at 30 months of age, the reporter stated that the child began to display symptoms of neurological damage consistent with mercury poisoning. Those symptoms included regression of language skills, developmental delays, lack of fine motor control, limited attention span and diminished cognitive ability. In 2002, the attorney alleges that the child was dx'd with mercury poisoning which has caused him to suffer permanent injuries. The reporter attributed these events to the presence of thimerosal. The child received unspecified treatments and his parents allege that they have noted "modest" improvement as mercury levels decrease.
Patient does have a baseball-sized red area around the vaccination site. It is not warm to the touch but is slightly raised. She also reported on 10/4 that she has been feeling like she could pass out since last night. She also said her blood sugar is running lower than usual. I did contact her PCP on this end and encouraged her to do so as well.
12:40 RED PINPOINT AREAS ON RIGHT ARM STARTED WITH 2" THEN 3" TOOK BENADRYL 24 MG AT 1:10.  1:15 DOTS GROWING IN SIZE, LOOK LIKE SMALL BLISTERS.  "I FELT OFF BALANCE."
No additional AE reported.; Nurse reports that a twelve month old patient was accidently administered both VARIVAX and PROQUAD on Jul 5, 2022.; This spontaneous report has been received from a registered nurse concerning a 12-month-old patient of unknown gender. The concomitant medications, medical history, drug reactions or allergies, and concurrent conditions were not reported.  On 05-JUL-2022, the patient was accidently administered both measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) once, lot # W002785, expiration date 24-JUL-2023 (strength, dose, route of administration and anatomical location were not provided) and varicella virus vaccine live (oka/merck) (VARIVAX) once, lot # U029496, expiration date 21-SEP-2023 (strength, dose, route of administration and anatomical location were not provided) for prophylaxis (accidental overdose). No further information was provided. No additional adverse event (AE) was reported. No product quality complaints (PQC) was reported.
Vaccine may have been stored under conditions that departed from the manufacture's recommended specifications. the manufacture deems the vaccine is not to be viable. No harm was caused; however, the patient may not received the optimum benefit of the vaccine.
Pt received both doses of pfizer covid vaccine; Covid test post vaccination result: Positive; Pt received both doses of pfizer covid vaccine; Covid test post vaccination result: Positive; This is a spontaneous report from a contactable other health care professional. A 58-year-old non-pregnant female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN 3518), via intramuscular route of administration on 21Jan2021 (at the age of 57 years old) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6201), via intramuscular route of administration on 10Feb2021 as dose 2, single for covid-19 immunisation. At other facility the most recent COVID-19 vaccine was administered. Medical history included asthma, chronic pain, prediabetes and hypertension (HTN). The patient had no known allergies. Concomitant medications the patient received within 2 weeks of vaccination included amlodipine, gabapentin, fluticasone propionate, salmeterol xinafoate (ADVAIR), hctz, meloxicam, metformin, montelukast, tramadol; all were taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient received both doses of pfizer covid vaccine and had covid test post vaccination result: positive on 28Jun2021. The patient underwent lab tests and procedures which included rapid PCR: positive on 28Jun2021 (nasal swab). The events resulted in a visit to physician office. The patient did not receive any treatments for the events. Reporter considered events as non-serious. Outcome of the events was recovering.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, there is individual variation in how the body respond in developing antibodies to the vaccine.
After shot was given Mom reports she slid out of the chair and was quite pale and eyes rolled back. We laid her down and gave juice. She was awake and alert for 3 minutes. She waited 10 minutes and then went home.
Fatigue beginning in the evening, chills and fever the night of, 24 hrs after injection fatigue, aches, red/non itchy rash on feet and calves, second night night sweats, 48 hrs after injection mild fatigue, rash, 72 hrs after injection, mild fatigue, rash (not spreading but not going away)
Information has been received from a consumer concerning her son who approximately 4-5 years ago was vaccinated with a dose of MMR II and immediately stopped talking. The consumer reported that her son has had several years of speech therapy to correct the problem. Unspecified medical attention was sought. Upon internal review, stopped talking was considered an other important medical event (OMIC). Additional info is not expected.
Day 1 injection site pain, Day 2 extreme fatigue and temperature of 100.4, injection site red, warm with a 5 cm hardened lump, Day 3 injection site red, warm with a 3 cm hardened lump, day 4 injection site remain red and warm, no longer swollen
Reported diffused rash to chest and back ~2 hours after recieving Pfizer COVID-19 vaccine on 12/18/2020.  Self-medicated with famotidine40 mg, cetirizine 10 mg, and Singulair 10mg at home.  Rash improved next day,
1st injection - Broke out in red bumps all over my torso. Very itchy and became the size of a quarter. I used Benadryl cream and Calamine Lotion. They did not go away before I received my second injection. 2nd injection - Same as above, except bumps went to my face, legs and arms along with my torso
Patient states about a day after getting shot she experienced itching under her underarms, in her groin area, and behind her knees. Then hives appeared (not severe). They went away after 3 days. Patient did not take any antihistamine for them.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with unspecified improperly stored GARDASIL 9 (reported lot # K006124, with expiration date 02-FEB-2017 and L038135 with expiration 27-MAY-2017, both were not valid). The vaccines were exposed to 9.7 degrees centigrade for a cumulative time frame of 4 hours and 41 minutes. There was no previous excursion. This report was for data logger. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received a flu vaccine on the evening on 9/24/19.   Patient reported that he woke up and the area was red and itchy.   He applied Cortisone cream for the itching.   He came in to ask what else he could use for the itching.  He showed me and the area was red and looked like a whelp.  It was on a large area on the upper part of his arm.  He said it did not have any heat to it, was just itchy.  He is going to continue using the steroid cream and may take some oral Benadryl.  If that doesn't work and it is still itchy, he may see his doctor for treatment.
fever; chills; This is a spontaneous report from a contactable Other HCP. This 69-year-old female Other HCP reported for herself that: A 69-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 14Feb2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 69-year-old) as single dose for covid-19 immunisation. Patient reported I am immunocompromised, and I have Antiphospholipid syndrome, I took the first two doses. I don't have cancer and I don't take steroids. I had a reaction to the second dose I know it's the same. Should I even attempt to take the third dose. I don't think I will have a reaction when asked what reactions she experienced patient stated the typical reactions fever and chills. It was the second dose I took on 14Feb. It's been so long ago I don't even remember. This agent confirmed with the caller that she is speaking of the Pfizer Covid 19 Vaccine. This case assessed as non-serious by the reporter. The outcome of the events was reported as unknown.  Information on the lot/batch number has been requested
After the vaccine, I had a low grade and tiredness for a day. For COVID-19 on 8/5/22, I had a headache, sore threat and a runny nose, coughing, fever temperature 101.2. I was really tired. I had chills and shaking. I was super tired and fatigued. The ever came down with TYLENOL. I still had the fever for maybe 2 days. I started taking PAXLOVID on 5AUG22. I did not see a doctor but communicated via online portal. I had known for a few days that I was exposed. The cough never went away but it got better.
Local redness induration heat, swelling, 7x9cm at vaccine site, left thigh 1 day after vaccine, IM Benadryl in Rocephin
It is not itchy; appeared a reddish rush on patient´s torso, stomach, back, face, around her neck and her chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (appeared a reddish rush on patient´s torso, stomach, back, face, around her neck and her chest) and PRURITUS (It is not itchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Red rash. Concomitant products included allergy medication since, nasal spray every morning, Claritin for congestion and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced RASH ERYTHEMATOUS (appeared a reddish rush on patient´s torso, stomach, back, face, around her neck and her chest). On an unknown date, the patient experienced PRURITUS (It is not itchy). At the time of the report, RASH ERYTHEMATOUS (appeared a reddish rush on patient´s torso, stomach, back, face, around her neck and her chest) and PRURITUS (It is not itchy) outcome was unknown. Not Provided          Treatment details included No   Reporter did not allow further contact
Swelling to area, low site of injection, warmth, redness, hard area, square looking raised redenned area, pain
arms are aching; woke up yesterday and from his shoulder to his elbow on his left arm is sore; This is a spontaneous report from a contactable consumer.   A 79-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was unknown, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 13Feb2021 13:15 (at the age of 79-years-old) as dose 1, single for covid-19 immunisation. Patient received second dose of BNT162B2 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation on 06Mar2021. Family Medical History Relevant to AE was none, but patient stated that he had 2 sisters who died from cancer on an unspecified date. Patient stated he had blood work done prior to getting the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient stated that he takes blood pressure medication, cholesterol medication, and fish oil and he wears a patch for his blood pressure (names of the products unknown).Vaccine administered at clinic. None of the vaccines was administered on same date of the Pfizer suspect vaccine. On 18Feb2021, patient stated that when he woke up yesterday morning his arms are aching and the left is the sorest, said he received the vaccine in the left arm also said that his right arm is sore at the elbow. Patient had no visit to emergency room or physician office. Outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Patient was inadvertently administered 2 doses of expired Twinrix on 1/18/2023 and 2/17/2023. Patient was contacted and reported no serious side effects.
Severe Diarrhea and fever (about 100) started on day of injection (2-2-21) and lasted about 1 week.  During this time I noticed loss of movement and strength in both legs.  This continued to worsen. By about 2-23-21 (day I received 2nd dose) muscles in legs were very constricted making it difficult to walk.  Plus I have lost strength in both hands. Contacted my doctor who refereed me to a Neurologist  .  The Neurologist ran tests on 3-5-21 that indicate that I have nerve damage.  Doing physical therapy in an attempt to loosen muscle constriction and regain strength.
Daughter called 10-4-08 reporting her mother's right arm was very red clear down past the elbow, hot to the touch and painful.  Daughter is an RPh and had instructed mom to ice it and take Tylenol for the pain - will keep an eye on it and see MD on Monday if needed.
Pt develop a rash consistent with erythema multiforme minor approximately five days after receiving his two month immunizations.
Employee c/o of sudden loss of vision and  fell forward on the floor. Employee states he did not have any lunch yet. Emergency team called and assess the employee.  Client refused to be taken to the ER for further evaluation. VS monitored and stable . No SOB, no difficulty of breathing.  No Taking po fluids.  Client d/c with steady gait and no c/o.
It was reported that a 5-year-old male received his fifth dose of DTAP on 1/8/02 administered in the left anterior thigh. The next day, his thigh was red, swollen and hot to the touch in a 17x18cm area. The patient had a 104F fever which came down to 103F after medicated with Motrin. He was seen by a physician on 1/9/02 and 1/10/02.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in a 43-year-old female subject who was vaccinated with ENGERIX B adult (GlaxoSmithKline). On unspecified dates the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B adult (unknown, unknown deltoid). Subsequently, on unspecified dates, the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B adult (unknown, unknown deltoid) as a 2nd series. An on unspecified dates, the subject received 1st dose, 2nd dose and 3rd dose of ENGERIX B adult (unknown, unknown deltoid) as a 3rd series. On unspecified dates, over 30 days after each vaccination series with ENGERIX B adult, the subject experienced not responding to therapy. The healthcare professional reported that an adult female experienced "lack of expected response" after 3 series of ENGERIX B vaccinations. The subject received a total of 3 full series with ENGERIX B (adult dose) at another clinic that was reportedly given correctly. Titres were drawn over 30 days after each series was completed and the subject had not seroconverted. No dates were provided.
equilibrium is all off; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Mar2021 14:00 (Lot number: EN6205) at the age of 67 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetes; "vascular disease" (unspecified if ongoing), notes: Verbatim: vascular disease. There were no concomitant medications. Vaccination history included: Bnt162b2 (1st Dose, Lot/batch number: EN9581), administration date: 19Feb2021, for COVID-19 Immunisation. The following information was reported: BALANCE DISORDER (non-serious) with onset 12Mar2021 01:00, outcome "unknown", described as "equilibrium is all off". Therapeutic measures were not taken as a result of balance disorder.  Additional Information: for Other Conditions, Reporter said this was diagnosed years ago, his blood veins had a lot of calcium in them, and he was losing blood flow to his legs, so they did an extra bypass inside him to get more blood to his legs. Reporter said he got his second Pfizer COVID-19 vaccination shot Tuesday afternoon and woke up this morning and his equilibrium is all off, to where if he stands up fast, he has got to stop. He says actually at a normal pace, not real fast, or if he turns. He says he would like to know if this is normal, since he got his shot last Tuesday. he got his vaccine doses at hospital. Reporter said he got his second shot on 09Mar2021 at 02:00PM, and his equilibrium was off this morning first when he got up at 01:00AM. He says he flipped the covers off and it was totally weird, and he laid there then rolled over and got up and almost fell over. He says he has a urinal by the bed, he had to stand with his hand on the wall. He said that the first dose he got of the Pfizer COVID-19 vaccine was LOT EN9581 and was given 19Feb2021, which he had absolutely no side effects from it at all. He said his second dose on 09Mar2021 was LOT EN6205. For concomitant Medications, Reporter said they have not had any other recent vaccinations or started any new medications. Reporter said something about not having any for two weeks when asked about new medications or recent vaccinations, caller does not clarify this statement. Reporter said that he has done no treatment for his equilibrium being off. He said he just woke up with that this morning. He said it seems it has gotten better after he got out of bed at 06:00AM he has been lounging in his chair and can get up and move better, he just has to move slowly.  No follow-up attempts are possible. No further information is expected.
I developed a painful, pruritic maculo-papillary rash. It covered my entire body including my neck and face. It continues to this day?July 4 2021. It begins as a rash that resembles a herpes  lesion, and progresses to weeping, scabbing, and encrustations. It was weakly responsive to a15 day course of prednisone but returned at full force when it was stopped. Topical steroids provide only symptomatic relief. It remains a severe pruritic, painful rash.
Moderate rash on chest, torso, and armpits.; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 29Apr2021 at 08:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 08Apr2021 at 07:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021, the patient experienced moderate rash on chest, torso and armpits. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event moderate rash on chest, torso and armpits was not recovered.   No follow-up attempts are needed. No further information is expected.